Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11355)
All Articles published online
|
Publishing Process of This Article
|
Sep 7, 2016 (publication date) through Dec 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kimbara S, Kondo S. Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma. World J Gastroenterol 2016; 22(33): 7440-7452 [PMID: 27672267 DOI: 10.3748/wjg.v22.i33.7440] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i33/7440.htm |
| Number | Citing Articles |
| 1 |
Emily Rodrigues, Matthew Macauley. Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities. Cancers 2018; 10(6): 207 doi: 10.3390/cancers10060207
|
| 2 |
Bo Ren, Ming Cui, Gang Yang, Huanyu Wang, Mengyu Feng, Lei You, Yupei Zhao. Tumor microenvironment participates in metastasis of pancreatic cancer. Molecular Cancer 2018; 17(1) doi: 10.1186/s12943-018-0858-1
|
| 3 |
Jingmin Shen, Chao Sun, Zhicheng Wang, Zhijie Chu, Chengcheng Liu, Xuelian Xu, Ming Xia, Miaoqing Zhao, Cheng Wang. Sequential receptor–mediated mixed-charge nanomedicine to target pancreatic cancer, inducing immunogenic cell death and reshaping the tumor microenvironment. International Journal of Pharmaceutics 2021; 601: 120553 doi: 10.1016/j.ijpharm.2021.120553
|
| 4 |
Noriyuki Hirahara, Yoshitsugu Tajima, Takeshi Matsubara, Yusuke Fujii, Shunsuke Kaji, Yasunari Kawabata, Ryoji Hyakudomi, Tetsu Yamamoto, Yuki Uchida, Takahito Taniura. Systemic Immune-Inflammation Index Predicts Overall Survival in Patients with Gastric Cancer: a Propensity Score–Matched Analysis. Journal of Gastrointestinal Surgery 2021; 25(5): 1124 doi: 10.1007/s11605-020-04710-7
|
| 5 |
JeongMin Sim, JeongMan Park, Suwan Kim, Sojung Hwang, KyoungSu Sung, Jung-Eun Lee, SeungHo Yang, Kyunggi Cho, SungHwan Lee, Jong-Seok Moon, JuWon Ahn, Jaejoon Lim. Association of Tim-3/Gal-9 Axis with NLRC4 Inflammasome in Glioma Malignancy: Tim-3/Gal-9 Induce the NLRC4 Inflammasome. International Journal of Molecular Sciences 2022; 23(4): 2028 doi: 10.3390/ijms23042028
|
| 6 |
Sariah A. Kell, Melissa A. Kachura, Alex Renn, Paula Traquina, Robert L. Coffman, John D. Campbell. Preclinical development of the TLR9 agonist DV281 as an inhaled aerosolized immunotherapeutic for lung cancer: Pharmacological profile in mice, non-human primates, and human primary cells. International Immunopharmacology 2019; 66: 296 doi: 10.1016/j.intimp.2018.11.019
|
| 7 |
Jérémy Nigri, Meritxell Gironella, Christian Bressy, Elena Vila-Navarro, Julie Roques, Sophie Lac, Caroline Bontemps, Coraline Kozaczyk, Jérôme Cros, Daniel Pietrasz, Raphaël Maréchal, Jean-Luc Van Laethem, Juan Iovanna, Jean-Baptiste Bachet, Emma Folch-Puy, Richard Tomasini. PAP/REG3A favors perineural invasion in pancreatic adenocarcinoma and serves as a prognostic marker. Cellular and Molecular Life Sciences 2017; 74(22): 4231 doi: 10.1007/s00018-017-2579-9
|
| 8 |
Jingchang Zhang, Renfeng Li, Shuai Huang. The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.951019
|
| 9 |
A. Fucic, A. Aghajanyan, Z. Culig, N. Le Novere. Systems Oncology: Bridging Pancreatic and Castrate Resistant Prostate Cancer. Pathology & Oncology Research 2019; 25(4): 1269 doi: 10.1007/s12253-018-0467-8
|
| 10 |
Dominique Lombardo, Françoise Silvy, Isabelle Crenon, Emmanuelle Martinez, Aurélie Collignon, Evelyne Beraud, Eric Mas. Pancreatic adenocarcinoma, chronic pancreatitis, and MODY-8 diabetes: is bile salt-dependent lipase (or carboxyl ester lipase) at the crossroads of pancreatic pathologies?. Oncotarget 2018; 9(15): 12513 doi: 10.18632/oncotarget.23619
|
| 11 |
Junhao Xie, Xianzhu Zhou, Rui Wang, Jiulong Zhao, Jian Tang, Qichen Zhang, Yiqi Du, Yanan Pang. Identification of potential diagnostic biomarkers in MMPs for pancreatic carcinoma. Medicine 2021; 100(23): e26135 doi: 10.1097/MD.0000000000026135
|
| 12 |
Nikolaos Vitorakis, Antonios N. Gargalionis, Kostas A. Papavassiliou, Christos Adamopoulos, Athanasios G. Papavassiliou. Precision Targeting Strategies in Pancreatic Cancer: The Role of Tumor Microenvironment. Cancers 2024; 16(16): 2876 doi: 10.3390/cancers16162876
|
| 13 |
Shahed N. Badiyan, Jason K. Molitoris, Michael D. Chuong, William F. Regine, Adeel Kaiser. The Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant Settings. Surgical Oncology Clinics of North America 2017; 26(3): 431 doi: 10.1016/j.soc.2017.01.012
|
| 14 |
Noriyuki Hirahara, Yoshitsugu Tajima, Yusuke Fujii, Tetsu Yamamoto, Ryoji Hyakudomi, Takanori Hirayama, Takahito Taniura, Kazunari Ishitobi, Akihiko Kidani, Yasunari Kawabata. A Novel Prognostic Scoring System Using Inflammatory Response Biomarkers for Esophageal Squamous Cell Carcinoma. World Journal of Surgery 2018; 42(1): 172 doi: 10.1007/s00268-017-4144-y
|
| 15 |
Shumin Qiu, Chongmin Jiang, Lin Zhou. Physical activity and mortality in patients with colorectal cancer: a meta-analysis of prospective cohort studies. European Journal of Cancer Prevention 2020; 29(1): 15 doi: 10.1097/CEJ.0000000000000511
|
| 16 |
Yan-Bo Zheng, Meng-Ran Zhang, Yi Li, Xiu-Jun Liu, Yong-Su Zhen. DBDx-based drug combinations show highly potent therapeutic efficacy against human pancreatic cancer xenografts in athymic mice. Cancer Biology & Therapy 2020; 21(8): 749 doi: 10.1080/15384047.2020.1776580
|